Joanne M. Bowen

12.2k total citations · 2 hit papers
171 papers, 9.0k citations indexed

About

Joanne M. Bowen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Joanne M. Bowen has authored 171 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pulmonary and Respiratory Medicine, 97 papers in Oncology and 63 papers in Otorhinolaryngology. Recurrent topics in Joanne M. Bowen's work include Oral health in cancer treatment (105 papers), Head and Neck Cancer Studies (63 papers) and Cancer Diagnosis and Treatment (34 papers). Joanne M. Bowen is often cited by papers focused on Oral health in cancer treatment (105 papers), Head and Neck Cancer Studies (63 papers) and Cancer Diagnosis and Treatment (34 papers). Joanne M. Bowen collaborates with scholars based in Australia, United States and Netherlands. Joanne M. Bowen's co-authors include Rachel J. Gibson, Dorothy Keefe, Andrea M. Stringer, Richard M. Logan, Hannah R. Wardill, Stephen T. Sonis, Rajesh V. Lalla, Ann S. J. Yeoh, Elad Sharon and Ysabella Van Sebille and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Joanne M. Bowen

166 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

2014 768 citations Joanne M. Bowen, Dorothy Keefe et al. profile →
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

2020 573 citations Richard M. Logan, Joanne M. Bowen et al. profile →

Peers

Countries citing papers authored by Joanne M. Bowen

Since Specialization

Citations

This map shows the geographic impact of Joanne M. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne M. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne M. Bowen more than expected).

Fields of papers citing papers by Joanne M. Bowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne M. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne M. Bowen. The network helps show where Joanne M. Bowen may publish in the future.

Co-authorship network of co-authors of Joanne M. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne M. Bowen. A scholar is included among the top collaborators of Joanne M. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne M. Bowen. Joanne M. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary interventions and tumor response to chemotherapy in breast cancer: A comprehensive review of preclinical and clinical data 2024 ·Clinical Nutrition ESPEN ·(unknown), Hannah R. Wardill, Janet K. Coller, Joanne M. Bowen	1
2	Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy 2023 ·Cancer Chemotherapy and Pharmacology ·(unknown), Joanne M. Bowen, Rachel J. Gibson, (unknown), Kate R. Secombe, (unknown), Richard M. Logan, Jonathan Tuke, (unknown), (unknown), Christos S. Karapetis, Dorothy Keefe, Janet K. Coller	3
3	Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study 2023 ·Supportive Care in Cancer ·Ghanyah Al-Qadami, Joanne M. Bowen, Ysabella Van Sebille, Kate R. Secombe, (unknown), Johan Verjans, Hannah R. Wardill, Hien Le	23
4	Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy 2023 ·Cell Death and Disease ·Hannah R. Wardill, (unknown), Himanshu Kumar, Emma Bateman, (unknown), Joanne M. Bowen, Rick Havinga, Hermie J. M. Harmsen, Jan Knol, Bram Dorresteijn, Miriam van Dijk, Jeroen van Bergenhenegouwen, Wim J. E. Tissing	8
5	Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats 2022 ·Neoplasia ·Kate R. Secombe, (unknown), Anthony Wignall, Emma Bateman, Dorothy Keefe, Joanne M. Bowen	11
6	Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities 2022 ·Microorganisms ·Ghanyah Al-Qadami, Kate R. Secombe, (unknown), Hannah R. Wardill, Joanne M. Bowen	102
7	Role of ErbB1 in the Underlying Mechanism of Lapatinib‐Induced Diarrhoea: A Review 2022 ·BioMed Research International ·(unknown), Jesmine Khan, Mohammad Johari Ibahim, (unknown), Joanne M. Bowen, (unknown)	4
8	Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment 2021 ·Cancer Chemotherapy and Pharmacology ·Kate R. Secombe, (unknown), (unknown), Hannah R. Wardill, Rachel J. Gibson, Janet K. Coller, Joanne M. Bowen	6
9	Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols 2021 ·Gut Microbes ·Kate R. Secombe, Ghanyah Al-Qadami, (unknown), Joanne M. Bowen, (unknown), Ysabella Van Sebille, Matthew Snelson, Caitlin S.M. Cowan, Gerard Clarke, Cassandra E. Gheorghe, John F. Cryan, Hannah R. Wardill	53
10	Epithelial-Specific TLR4 Knockout Challenges Current Evidence of TLR4 Homeostatic Control of Gut Permeability 2021 ·Inflammatory Intestinal Diseases ·(unknown), Joanne M. Bowen, Kate R. Secombe, Janet K. Coller, Maxime François, Wayne R. Leifert, Hannah R. Wardill	4
11	Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers 2020 ·Cancers ·(unknown), Joanne M. Bowen, Andrea J. Yool	24
12	Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome 2020 ·Integrative Cancer Therapies ·Kate R. Secombe, Ysabella Van Sebille, Bronwen J. Mayo, Janet K. Coller, Rachel J. Gibson, Joanne M. Bowen	48
13	Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant 2020 ·Breast Cancer ·Kate R. Secombe, (unknown), (unknown), Anthony Wignall, Dorothy Keefe, Joanne M. Bowen	9
14	Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model 2018 ·Cancer Chemotherapy and Pharmacology ·Kate R. Secombe, (unknown), (unknown), Anthony Wignall, John Finnie, Dorothy Keefe, Francesca Avogadri-Connors, Elizabeth Olek, (unknown), Susan Moran, Joanne M. Bowen	11
15	The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicity 2018 ·International Journal of Cancer ·Kate R. Secombe, Janet K. Coller, Rachel J. Gibson, Hannah R. Wardill, Joanne M. Bowen	61
16	Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis 2014 ·Adelaide Research & Scholarship (AR&S) (University of Adelaide) ·Bronwen J. Mayo, Andrea M. Stringer, Emma Bateman, Joanne M. Bowen, Anthony Wignall, (unknown), (unknown), Claudio Pietra, Sergio Cantoreggi, (unknown)	1
17	Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update 2012 ·Supportive Care in Cancer ·Joanne M. Bowen, Elad Sharon, Ronald D. Hutchins, (unknown)	39
18	Further characterisation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor-induced diarrhoea 2011 ·Supportive Care in Cancer ·Emma Bateman, Joanne M. Bowen, Bronwen J. Mayo, (unknown), (unknown), Andrea M. Stringer, (unknown), Dorothy Keefe	1
19	HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract 2009 ·Current Drug Targets ·Noor Al‐Dasooqi, Rachel J. Gibson, Joanne M. Bowen, Dorothy Keefe	18
20	Prolactin Induces ERK Phosphorylation in Epithelial and CD56⁺Natural Killer Cells of the Human Endometrium 2002 ·The Journal of Clinical Endocrinology & Metabolism ·O Gubbay, Hilary Critchley, Joanne M. Bowen, Ashley King, Henry N. Jabbour	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact